⌘K

Xilio Therapeutics, Inc. (XLO)

$0.81 0.58% $0.00 Healthcare

Xilio Therapeutics, Inc., a clinical-stage biotechnology company, develops immunotherapies to improve the immune system of cancer patients. Its checkpoint inhibitor program includes XTX101, a clinical-stage, tumor-selective anti-CTLA-4 mAb that is in Phase 1/2 clinical trials in patients with solid tumors. The company also develops cytokine programs, which comprises XTX202, a modified form of IL-2; XTX301, an IL-12 product candidate; and XTX401, an IL-15 product candidate that are masked with a protein domain to prevent binding activity until cleaved off by tumor microenvironment (TME)-associated proteases. Xilio Therapeutics, Inc. was founded in 2016 and is headquartered in Waltham, Massachusetts.

Market cap

$35.81M

CEO

Dr. Rene Russo BCPS, Pharm.D, Pharm.D.

Full time employees

74.00

Headquarters

Waltham, MA

IPO Date

Oct 22, 2021

Price-to-earnings (PE) Ratio

-0.41

Earnings-per-share (EPS)

$-1.98

Cash ratio (TTM)

4.63

Current ratio (TTM)

4.81

Net profit margin (TTM)

0.00%

PE ratio (TTM)

-0.37

PEG ratio (TTM)

0.00

Price-to-book ratio (TTM)

0.45

Price-to-sales ratio (TTM)

0.00

Quick ratio (TTM)

4.63

Return on assets (TTM)

-88.53%

Return on equity (TTM)

-85.14%

Similar stocks (11)

Edgewise Therapeutics, Inc.

EWTX

$19.07 5.50% $1.00

Uptrend

Tyra Biosciences, Inc.

TYRA

$23.20 3.76% $0.84

Uptrend

Eliem Therapeutics, Inc.

ELYM

$7.98 0.25% $0.02

Uptrend

Design Therapeutics, Inc.

DSGN

$5.64 -2.25% $-0.13

Uptrend

Ikena Oncology, Inc.

IKNA

$1.66 -0.60% $-0.01

Neutral

MediciNova, Inc.

MNOV

$1.55 -8.28% $-0.14

Neutral

RAPT Therapeutics, Inc.

RAPT

$1.82 -4.21% $-0.08

Downtrend

Champions Oncology, Inc.

CSBR

$4.28 -6.96% $-0.32

Downtrend

Aerovate Therapeutics, Inc.

AVTE

$1.91 0.00% $0.00

Downtrend

Anebulo Pharmaceuticals, Inc.

ANEB

$2.00 -11.89% $-0.27

Downtrend

AN2 Therapeutics, Inc.

ANTX

$1.06 0.00% $0.00

Downtrend

ETF Exposure (6)

iShares Micro-Cap ETF

IWC

0.006%

$123.83 0.30% $0.37

Uptrend

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

$136.02 0.03% $0.04

Uptrend

Vanguard Total Stock Market Index Fund

VITSX

$134.99 -0.24% $-0.33

Uptrend

Vanguard Total Stock Market Index Fund

VTI

$277.35 -0.25% $-0.70

Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

$134.97 -0.24% $-0.33

Uptrend

Vanguard Extended Market Index Fund

VXF

$179.34 0.03% $0.06

Uptrend

Downtrend

Similar stocks (11)

Edgewise Therapeutics, Inc.

EWTX

$19.07 5.50% $1.00

Uptrend

Tyra Biosciences, Inc.

TYRA

$23.20 3.76% $0.84

Uptrend

Eliem Therapeutics, Inc.

ELYM

$7.98 0.25% $0.02

Uptrend

Design Therapeutics, Inc.

DSGN

$5.64 -2.25% $-0.13

Uptrend

Ikena Oncology, Inc.

IKNA

$1.66 -0.60% $-0.01

Neutral

MediciNova, Inc.

MNOV

$1.55 -8.28% $-0.14

Neutral

RAPT Therapeutics, Inc.

RAPT

$1.82 -4.21% $-0.08

Downtrend

Champions Oncology, Inc.

CSBR

$4.28 -6.96% $-0.32

Downtrend

Aerovate Therapeutics, Inc.

AVTE

$1.91 0.00% $0.00

Downtrend

Anebulo Pharmaceuticals, Inc.

ANEB

$2.00 -11.89% $-0.27

Downtrend

AN2 Therapeutics, Inc.

ANTX

$1.06 0.00% $0.00

Downtrend

ETF Exposure (6)

iShares Micro-Cap ETF

IWC

0.006%

$123.83 0.30% $0.37

Uptrend

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

$136.02 0.03% $0.04

Uptrend

Vanguard Total Stock Market Index Fund

VITSX

$134.99 -0.24% $-0.33

Uptrend

Vanguard Total Stock Market Index Fund

VTI

$277.35 -0.25% $-0.70

Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

$134.97 -0.24% $-0.33

Uptrend

Vanguard Extended Market Index Fund

VXF

$179.34 0.03% $0.06

Uptrend